| Chelsea Galutia, DO | |
|
11610 N 137th E Ave, Collinsville, OK 74021 | |
| (918) 272-2247 | |
| (918) 272-6185 |
| Full Name | Chelsea Galutia |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 11610 N 137th E Ave, Collinsville, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427000587 | NPI | - | NPPES |
| 200077550A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 4187 (Oklahoma) | Primary |
| Entity Name | Warren Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
The major challenge facing physicians treating Alzheimer's is the ability to detect markers of the disease as early as possible. These markers, located in the brain, are difficult to access, hampering diagnosis.
According to British scientists, people who regularly work long hours may be significantly increasing their risk of developing heart disease that could eventually kill them.
The numbers are, well, depressing: More than 2 million people age 65 and older suffer from depression, including 50 percent of those living in nursing homes. The suicide rate among white men over 85 is the highest in the country - six times the national rate.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax's lead product entinostat, a novel inhibitor of histone deacetylases (HDAC), and anastrozole, an aromatase inhibitor, in postmenopausal women with operable triple negative breast cancer to evaluate biomarkers and surrogates for response.
What's crucial for a diabetic's foot sore to heal is that the ulcer is superficial, blood circulation is normal, and the person has had diabetes for short time. This is shown in the world's largest diabetes study regarding foot ulcers, which has been carried out by the researcher Magdalena Annersten Gerhater at Malmö University in Sweden.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea Galutia, DO 6600 S Yale Ave Ste 1400, Tulsa, OK 74136-3331 Ph: (888) 247-0125 | Chelsea Galutia, DO 11610 N 137th E Ave, Collinsville, OK 74021 Ph: (918) 272-2247 |
News Archive
The major challenge facing physicians treating Alzheimer's is the ability to detect markers of the disease as early as possible. These markers, located in the brain, are difficult to access, hampering diagnosis.
According to British scientists, people who regularly work long hours may be significantly increasing their risk of developing heart disease that could eventually kill them.
The numbers are, well, depressing: More than 2 million people age 65 and older suffer from depression, including 50 percent of those living in nursing homes. The suicide rate among white men over 85 is the highest in the country - six times the national rate.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax's lead product entinostat, a novel inhibitor of histone deacetylases (HDAC), and anastrozole, an aromatase inhibitor, in postmenopausal women with operable triple negative breast cancer to evaluate biomarkers and surrogates for response.
What's crucial for a diabetic's foot sore to heal is that the ulcer is superficial, blood circulation is normal, and the person has had diabetes for short time. This is shown in the world's largest diabetes study regarding foot ulcers, which has been carried out by the researcher Magdalena Annersten Gerhater at Malmö University in Sweden.
› Verified 4 days ago
Dr. Pooja Parmar, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11610 N 137th E Ave, Collinsville, OK 74021 Phone: 918-272-2247 Fax: 918-272-6185 |